Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting.
作者信息
Kharfan-Dabaja Mohamed A, Pidala Joseph, Anasetti Claudio
出版信息
Blood. 2010 May 27;115(21):4316-7; author reply 4317. doi: 10.1182/blood-2010-01-265728.
Abstract
摘要
相似文献
1
Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting.使用他克莫司/西罗莫司预防移植物抗宿主病后的血栓性微血管病：呼吁在报告中使用共识定义。
Blood. 2010 May 27;115(21):4316-7; author reply 4317. doi: 10.1182/blood-2010-01-265728.
2
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.三种预处理方案的他克莫司/西罗莫司预防同胞供者造血干细胞移植后移植物抗宿主病的 II 期临床试验
Blood. 2010 Feb 4;115(5):1098-105. doi: 10.1182/blood-2009-03-207563. Epub 2009 Nov 19.
3
Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis.与他克莫司/西罗莫司为基础的移植物抗宿主病预防的异基因造血细胞移植后西罗莫司水平相关的血栓性微血管病。
Biol Blood Marrow Transplant. 2013 Feb;19(2):298-304. doi: 10.1016/j.bbmt.2012.10.006. Epub 2012 Oct 15.
4
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.他克莫司联合 MTX 或西罗莫司预防移植物抗宿主病的异基因造血干细胞移植受者发生血栓性微血管病的危险因素。
Bone Marrow Transplant. 2014 May;49(5):684-90. doi: 10.1038/bmt.2014.17. Epub 2014 Feb 24.
5
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.西罗莫司和他克莫司联合抗胸腺细胞球蛋白预防可降低异基因造血干细胞移植后急性移植物抗宿主病的风险，但无总体生存获益。
Biol Blood Marrow Transplant. 2011 Jun;17(6):916-22. doi: 10.1016/j.bbmt.2010.09.017. Epub 2010 Dec 4.
6
Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus.儿童患者接受西罗莫司和他克莫司治疗后的移植相关性血栓性微血管病。
Pediatr Blood Cancer. 2011 Jul 15;57(1):142-6. doi: 10.1002/pbc.22861. Epub 2010 Nov 23.
7
Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation.在接受清髓性异基因造血细胞移植的患者中，西罗莫司血浆浓度与肝脏窦状隙阻塞综合征可能存在相关性。
Pharmacotherapy. 2012 May;32(5):441-5. doi: 10.1002/j.1875-9114.2012.01034.x. Epub 2012 Apr 12.
8
Sirolimus-related systemic thrombotic microangiopathy after renal transplantation.肾移植术后西罗莫司相关性全身血栓性微血管病。
Therapie. 2014 Mar-Apr;69(2):175-7. doi: 10.2515/therapie/2014020. Epub 2014 Jun 12.
9
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis.采用他克莫司/西罗莫司预防移植物抗宿主病，联合强度降低的预处理方案进行异基因造血细胞移植治疗骨髓纤维化，可改善预后。
Biol Blood Marrow Transplant. 2010 Feb;16(2):281-6. doi: 10.1016/j.bbmt.2009.09.020. Epub 2009 Sep 26.
10
A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).一项关于西罗莫司联合他克莫司/甲氨蝶呤预防异基因造血细胞移植后儿童急性淋巴细胞白血病（ALL）移植物抗宿主病的 I/II 期安全性和有效性的研究。
Br J Haematol. 2009 Dec;147(5):691-9. doi: 10.1111/j.1365-2141.2009.07889.x. Epub 2009 Sep 10.
引用本文的文献
1
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.HLA-DRB1*11在造血干细胞移植相关血栓性微血管病的发生发展及预后中的潜在作用
Bone Marrow Transplant. 2015 Oct;50(10):1321-5. doi: 10.1038/bmt.2015.161. Epub 2015 Jul 6.
2
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.他克莫司联合 MTX 或西罗莫司预防移植物抗宿主病的异基因造血干细胞移植受者发生血栓性微血管病的危险因素。
Bone Marrow Transplant. 2014 May;49(5):684-90. doi: 10.1038/bmt.2014.17. Epub 2014 Feb 24.
本文引用的文献
1
A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.三种预处理方案的他克莫司/西罗莫司预防同胞供者造血干细胞移植后移植物抗宿主病的 II 期临床试验
Blood. 2010 Feb 4;115(5):1098-105. doi: 10.1182/blood-2009-03-207563. Epub 2009 Nov 19.
2
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.西罗莫司与清髓性异基因干细胞移植后肝静脉闭塞性疾病有关。
Blood. 2008 Dec 1;112(12):4425-31. doi: 10.1182/blood-2008-07-169342. Epub 2008 Sep 5.
Zotero 插件